Skip to main content
Back
Watch Compare

Evolus, Inc.

Data quality: 100%
EOLS
Nasdaq Manufacturing Chemicals
$4.20
▲ $0.11 (2.57%)
Mkt Cap: 272.93 M
Price
$4.20
Mkt Cap
272.93 M
Day Range
$4.02 — $4.27
52-Week Range
$3.86 — $12.28
Volume
591,350
Open $4.05
50D / 200D Avg
$4.61
9.04% below
50D / 200D Avg
$6.58
36.20% below

Quick Summary

Key Takeaways

Revenue grew 31.40% annually over 5 years — strong growth
Negative free cash flow of -45.71 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 19.79%
Capital efficient — spends only 1.16% of revenue on capex

Growth

Revenue Growth (5Y)
31.40%
Above sector avg (1.82%)
Revenue (1Y)11.61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-16.26%
Net Margin-17.38%
Op. Margin-10.99%

Safety

Debt / Equity
N/A
Current Ratio2.02
Interest Coverage-1.66

Valuation

PE (TTM)
-5.29
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -5.3 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % -17.4 -41.5
Rev Growth 5Y % 31.4 1.8
D/E — 0.3

ETFs Holding This Stock

PILL logo PILL Direxion Daily Pharmaceutical & Medical Bull 3X ETF
0.62% weight
MXMTX MXMTX
0.13% weight
IJSTX IJSTX
0.13% weight
IJSAX IJSAX
0.13% weight
IJSSX IJSSX
0.13% weight
VPRSX VPRSX
0.13% weight
IJSIX IJSIX
0.13% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.10% weight
QWVOX QWVOX
0.09% weight
AFSM logo AFSM First Trust Active Factor Small Cap ETF
0.06% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 11.61% Revenue Growth (3Y) 21.27%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 31.40% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 297.18 M Net Income (TTM) -51.64 M
ROE N/A ROA -23.06%
Gross Margin 66.33% Operating Margin -10.99%
Net Margin -17.38% Free Cash Flow (TTM) -45.71 M
ROIC -16.26% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.02
Interest Coverage -1.66 Asset Turnover 1.33
Working Capital 68.18 M Tangible Book Value -98.69 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5.29 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.92
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -16.75%
Market Cap 272.93 M Enterprise Value 375.18 M
Per Share
EPS (Diluted TTM) -0.80 Revenue / Share 4.57
FCF / Share -0.70 OCF / Share -0.65
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.16% FCF Conversion 88.51%
SBC-Adj. FCF -66.48 M Growth Momentum -19.79

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 297.18 M 266.27 M 202.09 M 148.62 M 99.67 M
Net Income -51.64 M -50.42 M -61.69 M -74.41 M -46.81 M
EPS (Diluted) -0.80 -0.81 -1.08 -1.33 -0.94
Gross Profit 197.11 M 182.30 M — — —
Operating Income -32.66 M -34.41 M -49.23 M -65.33 M -44.41 M
EBITDA — — — — —
R&D Expenses — — — — 2.06 M
SG&A Expenses 220.79 M 198.03 M 164.94 M 141.84 M 112.07 M
D&A 7.51 M 5.30 M 5.13 M 3.72 M 5.62 M
Interest Expense 19.69 M 18.74 M 13.83 M 9.10 M —
Income Tax 677,000.0 664,000.0 176,000.0 95,000.0 42,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 225.87 M 232.57 M 189.00 M 177.98 M 257.48 M
Total Liabilities 248.97 M 227.05 M 209.69 M 159.48 M 175.61 M
Shareholders' Equity -23.11 M 5.52 M -20.69 M 18.50 M 81.88 M
Total Debt 146.10 M 121.51 M 120.36 M 71.88 M 71.22 M
Cash & Equivalents 53.83 M 86.95 M 62.84 M 53.92 M 146.26 M
Current Assets 142.92 M 151.34 M 112.42 M 100.80 M 178.80 M
Current Liabilities 75.31 M 62.96 M 48.29 M 46.51 M 57.66 M